View Article

  • Formulation and Evaluation of a Polyherbal Gel Containing Solanum Xanthocarpum and Sarcostemma Acidum Plant Extracts

  • Principal of pharmacy Oriental University Indore, (M.P.)

Abstract

This study reports the formulation and evaluation of a polyherbal topical gel combining extracts of Solanum xanthocarpum and Sarcostemma acidum. The aim was to develop a stable, acceptable gel with enhanced antioxidant and antimicrobial properties for potential wound-care/dermatological application. Extracts were prepared by Soxhlet apparatus, standardized by phytochemical screening and total phenolic content (TPC). Gels were prepared using Carbopol 940 and Sodium CMC as gelling agent with glycerin and propylene glycol as humectants. The final formulations were evaluated for organoleptic properties, pH, viscosity, spreadability, homogeneity, extrudability, in vitro antioxidant , antimicrobial activity (agar-well diffusion), and accelerated stability. Results indicated good physical stability, pH compatible with skin.

Keywords

Solanum xanthocarpum, Sarcostemma acidum, polyherbal gel, Carbopol Sodium CMC, antioxidant, antimicrobial, topical formulation

Introduction

Topical Drug Delivery System

Topical drug formulations are designed to exert localized effects at the site of application by allowing the drug to penetrate the skin or mucous membrane layers1. One of the key advantages of this delivery route is the bypassing of first-pass metabolism, which can otherwise reduce drug effectiveness2. Additionally, topical preparations avoid the complications and discomforts associated with intravenous therapy and are not affected by gastrointestinal factors such as pH variation, enzymatic activity, or gastric emptying time3. Among the various types of topical formulations, semisolids—such as creams, gels, and ointments—are most commonly used. However, other forms like foams, sprays, medicated powders, solutions, and medicated adhesive patches are also widely utilized. Topical systems are often employed when other routes of drug delivery are ineffective or unsuitable, particularly in areas such as pain relief, birth control, and treatment of urinary incontinence.

 Advantages of Topical Drug Delivery Systems:

  • Avoidance of first-pass metabolism.
  • Convenient and easy to apply.
  • Avoid the risks and inconveniences of intravenous therapy and the varied conditions of absorption, such as pH changes, the presence of enzymes, gastric emptying time, etc5.
  • Achievement of efficacy with a lower total daily dosage of the drug by continuous drug input.
  • Avoids fluctuation in drug levels, as well as inter- and intrapatient variations.
  • Ability to easily terminate the medications when needed.
  • A relatively large area of application in comparison with the buccal or nasal cavity

Disadvantages of Topical Drug Delivery Systems:

  • Skin irritation of contact dermatitis
  • Poor permeability of some medications through the Skin.
  • Possibility of allergenic reactions.
  • Can be used only for drugs that require minimal plasma concentration for action
  • Enzymes in the epidermis may denature the drugs
  • Drugs of larger particle size are not easy to absorb through the Skin

Gels

Gels are semi-solid systems in which a liquid phase is dispersed within a three- dimensional polymer network, formed from natural or synthetic gums. These systems rely on a high degree of physical or chemical cross-linking to maintain their structure. Polymers commonly used in gel formulations include natural gums such as tragacanth, pectin, carrageenan, agar, and alginic acid, as well as synthetic and semi-synthetic agents like methylcellulose, hydroxyethyl cellulose, carboxymethyl cellulose, and Carbopols—a class of synthetic vinyl polymers containing ionizable carboxyl groups6.

MATERIAL & METHODS

5.1 Prliminary Investigation   

2.1 Collection of Plant Material

Solanum xanthocarpum and Sarcostemma acidum specimens were gathered from the Bhopal region. Dr. S. N. Verma, professor and head of the Department of Botany at SAGE University, Indore, Madhya Pradesh, confirmed the authenticity of the collected plants. A voucher specimen (No. IOS/Bot/SLF-033 and IOS/Bot/SLF-034) has been duly archived in the department for future reference.

2.1.2 Preparation of Plant Powder

After collection, the plant materials were shade-dried to preserve their phytochemical constituents. Once dried, they were coarsely powdered using a mechanical grinder. The powdered material was then passed through a #40 mesh sieve and stored in airtight containers for subsequent experimental procedures7.

2.2 Preparation of Extracts

Approximately 250 g each of Solanum xanthocarpum and Sarcostemma acidum (dried powder) were subjected to Soxhlet extraction. Initially, defatting was performed using petroleum ether, followed by exhaustive extraction using the selected solvents for about 36 hours. The process temperature was maintained between 40°C and 50°C. Ethanol was chosen as the solvent for S. xanthocarpum, while methanol was used for Sarcostemma acidum. After extraction, the solvents were evaporated under reduced pressure. The concentrated extracts were then vacuum dried using a rotary flash evaporator to obtain a semisolid mass. (Reference: Kokate, Gokhale et al., 2005)

Plant Details-

Reference

  1. Bozzuto Anne (2000). Homeopathy, Herbs and Hypnosis Common Practices, In Complementary and Alternative Medicine, Jacksonville Medicine.
  2. The Ayurvedic Phrmacopoeia of India., Government of India., Ministry of Health and Family Welfare., New Delhi.1999, Part I, Vol III, pp 235
  3. Kokate C.K., Purohit A.P. and Gokhale S.B. (2005). A Text-book of Pharmacognosy, 31st edition, Nirali Prakashan.
  4. Mukherjii P.K. (2001). Quality Control of Herbal Drugs, Business Horizon Publication, 1st Edition 1, 183-219.
  5. Singh S. K. (2002). Proceedings of Global Promotion of Tradition Medicine in View of Institute Industry Relationship, Faculty of Ayurveda, Banaras Hindu University, pp. 112–115.
  6. Duke J. A. and Bogenschutz-Godwin M. J. (1999). Natural Products from Plants, CRC Press, Boca Raton, FL, USA, 183–205.
  7.  Ara Tachjian (2010). Use of Herbal Products and Potential Interactions in Patients with Cardiovascular Diseases” Journal of the American College of Cardiology,
  8. G. Ulrich-Merzenich et al. “Drug development from natural products: exploiting synergistic effects”, International Journal of experimental biology,48, 2010, 208-219.
  9. Smith JK, Dykes R, Douglas JE, Krishnaswamy G and Berk S. (1999). Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA, 12; 281(18):1722-7.
  10. McFarlin BK, Flynn MG, Phillips MD, Stewart LK and Timmerman KL (2005). Chronic resistance exercise training improves natural killer cell activity in older women. J Gerontol A Biol Sci Med Sci., 60(10):1315-8.
  11. Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, McFarlin BK, Timmerman KL, Coen PM and Felker J (2005). Talbert E. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4. Brain Behav Immun., 19(5):389-97.
  12. Gleeson M. (2006). Immune system adaptation in elite athletes. Curr Opin Clin Nutr Metab Care. 9(6):659-65.
  13. Pedersen BK and Hoffman-Goetz L. 2000Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev., 80(3):1055-81.
  14. Ploeger HE, Takken T, de Greef MH and Timmons BW (2009). The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exerc Immunol Rev.; 15:6-41.
  15. Timmerman KL, Flynn MG, Coen PM, Markofski MM and Pence BD. (2008). Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise? J Leukoc Biol., 84(5):1271-8.
  16. Mackinnon LT. (2000). Chronic exercise training effects on immune function. Med Sci Sports Exerc., 32(7 Suppl): S369-76.
  17. Suzuki K, Nakaji S, Yamada M, Liu Q, Kurakake S, Okamura N, Kumae T, Umeda T and Sugawara K. (2003). Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Med Sci Sports Exerc., 35(2):348-55.
  18. Pilon Brad. (2011). Inflammation Affects Your Ability to Build Muscle. Inflammation Theory, Inflammation, Chronic Inflammation, Muscle Building, Health. Web. http://www.inflammationtheory.com
  19. Yonehara, N., Shibutani, T., and Inoki, R. 1987, J. Pharmacol. Exp. Ther., 242, 1071.
  20. Kulkarni, R.R., Patki, P.S. Jog, V.P., Gandage, S.G.and Patwardhan, B. 1991, J. Ethnopharmacol., 33, 91.
  21. Saxena, R.C., Nath, R., Palit, G., Nigam, S.K., and Bhargava, K.P. 1979, Indian J. Pharmacol., 11, 39.          
  22. M. Anilkumar (2010). Ethnomedicinal plants as anti-inflammatory and analgesic agents In Ethnomedicine: A Source of Complementary Therapeutics, Editor: Debprasad Chattopadhyay, Research Signpost, Trivandrum, Kerela, India, 267-293 ISBN: 978-81-308-0390-6.
  23. Kang, S.S., Cordell, A., Soejarto, D.D., and Fong, H.H.S. 1985, J. Natural Products, 48, 155.
  24. Jain S.K. (1991).  Dictionary of Indian Folk Medicine and Ethnobotany, Deep Publications, New Delhi.
  25. Anonymous (1992). Wealth of India: Raw materials. III. CSIR Publication and Information Directorate, New Delhi, 8.
  26. Sofowora A. (1993). Medicinal plants and traditional medicine in Africa, Polygraphic Ventures Ltd. Ibdan, 207.
  27. Sandoval-Chacon, M., Thompson, J.H., Zhang, X.J., Manick, E.E., Sadowska-
  28. Srivastava, K.C., and Mustafa, T.1992, Med. Hypotheses, 39, 342
  29. Surver, C. and Davis, F.A., Bioaviability and Bioequivalence, In Walter, K.A. (Ed.), Dermatological and Transdermal Formulation, Marcal Dekker, INC. NewYork , 119,2002, pp. 403,323,326,327,403.
  30. Stan-posthumd J.J., Vink J., Lecessies, Bruijn J.A., et al., “Topical Tretinoin Under Oocclusion on a Typical Navei”, 1998, 548.
  31. Ansel H.C., Allen L.V., “Pharmaceutical Dosage Forms and Drug Delivery System”, 7th edition, Lippincott Willams and Wilkens, Baltimore, 2000, 244-246,249-251, 253-255,264-265.
  32. Nayank S.H., Nkhat P.D., and Yeole P.G., “The Indian Pharmacist”, Vol. III, No. 27, Sept. 2004, 7-14.
  33. Misra A.N., “Controlled and Novel Drug Delivery”, CBS Publishers and Distributors, New Delhi,1997, 107-109.
  34. Misra A.N., “Controlled and Novel Drug Delivery”, CBS Publishers and Distributors, New Delhi,1997, 107-109.
  35. Banker G.B.S., Rodes C.T., “Modern Pharmacist”, 2nd edition, Vol. 40, Marcel Dekker, New York, 1979, 263-273, 283,286-287,299-311.
  36. Kikwai, L., Babu, R. J., Kanikkannan, N., Singh, M., Preformulation stability of spantide 2, A promising topical anti – inflammatory agent for the treatment of psoriasis and contact dermtises. J. Pharm. Pharmacol. 2005;56 (1): 19 – 25.
  37. Elias, P.M., Epidermal lipids, barrier function and desquamation. J. Invest. Dermatol. 1983;80: 44-49.
  38. Schreier, H., and Bouwstra, J., Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J. Control. Rel. 1991; 30:1-15.
  39. Hadgraft, J., Recent developments in topical and transdermal delivery. Eur. J.  Drug Metab.  Pharmacokinet. 1996: 21: 165 – 173
  40. Jain, S., Tiwari, A. K., Topical products, edited by Jain, N. K., 2005, In: Pharmaceutical Product Development, CBS Publication and Distributor, New Delhi, 2005;221-249.
  41. Bedde, H. E., Holman, F., Spies, A., Ponec, M., Freeze fracture electron microscopy on in vitro reconstructed human epidermis. J. Invest. Dermatol. 1989;95: 108 – 116.
  42. Touitou, E., Dayan. N., Bergelson. L., Gidin, B., Eliaz, M., Ethosmes – novel vesicular carrier for enhanced delivery: characterization and skin penetration properties. J. Control Rel. 2000; 65: 405-418.
  43. Sun, Y. M., Huang, J. J., Lin, F. C., Lal, J. Y., Biomaterials. 1997;18: 527 – 533.
  44. Touitou E, Godin B and Weiss C. Enhanced delivery of drugs into and across the skin by Hydroalcohalic carriers. Drug Development Research. 2000; 50:  406-415.
  45. Touitou et al, Ethosomes- efficiently delivering active agents to skin personal care, Jan.2005; 6(1): 71-74.
  46. Sanjay, Ethosomes:A promising tool for transdermal delivery of drug. www.pharmainfonet.com
  47. Bendas ER, Tadros MI. Enhanced transdermal delivery of Salbutamol Sulfate via ethosomes. AAPS PharmSci Tech. 2007; 8(4): Article 107.
  48. Touitou E, Dayan N and Bergelson L. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65: 403-418.
  49. Cevc. G, lipid vesicles and other colloids as drug carriers on the skin; Advanced drug delivery Reviews 2004; 56:675-711.

Photo
Tushar Prajapati
Corresponding author

Principal of pharmacy Oriental University Indore, (M.P.)

Photo
Dr. Sachin Jain
Co-author

Principal of pharmacy Oriental University Indore, (M.P.)

Dr. Sachin Jain, Tushar Prajapati*, Formulation and Evaluation of a Polyherbal Gel Containing Solanum Xanthocarpum and Sarcostemma Acidum Plant Extracts, Int. J. Sci. R. Tech., 2025, 2 (10), 180-192. https://doi.org/10.5281/zenodo.17328257

More related articles
Artificial Intelligence in Drug Discovery...
Sayali Pagire, Aadesh Varpe, Om Ugalmugale, Aditya Vighne, ...
Artificial intelligence in drug discovery and deve...
Shubham Gurule, Pratik Bhabad, Anuja Darade, Sahil Gawade, Rutuja...
Related Articles
A Review Article Impurity Scavengers Roadmap for Platinum Derivative Formulation...
Subhakanta Kanungo, Neeta Joshi, Rahul Jain, Swati Kohle, ...
Challenges and Innovations in Conducting Clinical Trials in Rare and Orphan Dise...
Mrudula Dhengale , Shivshankar Nagrik , Harsha Bathe , Prajakta Hage , Aachal Kawade , Neha Phopse ,...
Formulation and Development of Dental Gel for Anti-Inflammatory as Well As Analg...
Chandraprabha Dewangan, Sanjay Kumar Sahu, Devid Patel, Denees Sinha, Suman Sahu, Yogita Sahu, Dr. R...
More related articles
Artificial Intelligence in Drug Discovery...
Sayali Pagire, Aadesh Varpe, Om Ugalmugale, Aditya Vighne, ...
Artificial intelligence in drug discovery and development...
Shubham Gurule, Pratik Bhabad, Anuja Darade, Sahil Gawade, Rutuja Avhad, Sakshi Bhagat , ...
Artificial Intelligence in Drug Discovery...
Sayali Pagire, Aadesh Varpe, Om Ugalmugale, Aditya Vighne, ...
Artificial intelligence in drug discovery and development...
Shubham Gurule, Pratik Bhabad, Anuja Darade, Sahil Gawade, Rutuja Avhad, Sakshi Bhagat , ...